FDA Study Encompasses IMES System That May Hold Promise for Amputees
From: Rehab management - 02/05/2014

US Marine SSgt James Sides will reportedly serve as the first subject to
receive an implantable myoelectric sensor (IMES) system in a new US Food and
Drug Administration (FDA)  study. According to a news release from the Alfred
Mann Foundation (AMF), the experimental system may have implications as a
minimally invasive, intuitive, multi-channel control system for prosthetics
intended for long-term use.

The release notes that the IMES System is currently being studied under the
Investigational Device Exemption (IDE) regulations of the FDA. AMF notes that
in its ongoing trial with injured veterans at the Walter Reed National
Medical Military Center, it anticipates subjects operating three prosthetic
movements simultaneously. These movements include the opening and closing of
the hand, rotating the wrist, and moving the thumb. The combination of these
movements would allow for several grasps key for performing daily tasks, the
release says.

Read the entire article at:
http://www.rehabpub.com/2014/02/fda-study-encompasses-imes-system-may-hold-promise-amputees/

Links:
US Marine First Subject in FDA Study for Highly Anticipated IMES System (with
  video 2:04) 
http://www.multivu.com/mnr/65112-alfred-mann-foundation-u-s-marine-subject-fda-study-for-imes-system

Alfred Mann Foundation
http://aemf.org/

Limb Loss
http://aemf.org/our-research/current-focus/limb-loss/